NL-OMON50726招募中不适用
Ischemia (FFR) Driven Complete Revascularization versus Usual Care in Patients with Non-ST Elevation Myocardial Infarction and Multivessel Diseases. - SLIM trial
Zuyderland Medisch Centrum0 个研究点目标入组 414 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 414
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Non-STEMI patients undergo successful PCI of the culprit lesion and have at
- •least one stenosis of >=50% in a non-culprit lesion feasible for treatment with
排除标准
- •Left main stem disease (stenosis > 50%)
- •Chronic total occlusion of a non-culprit lesion
- •Indication for or previous Coronary artery bypass grafting
- •Known severe cardiac valve dysfunction that will require surgery or TAVI in
- •the follow-up period.
- •Killip class III or IV during the completion of culprit lesion treatment.
- •Life expectancy of less than 1 year
- •Intolerance to Aspirin, or thienopyridine inhibitors or Heparin
- •Planned elective surgical procedure necessitating interruption of
- •thienopyridines during the first 3 months post enrolment
研究者
相似试验
尚未招募
不适用
Ischemia (FFR) Driven Complete Revascularization versus Usual Care in Patients with Non-ST Elevation Myocardial Infarction and Multivessel Diseases. The South Limburg Myocardial Infarction Study GroupNSTEMINL-OMON23247Zuyderland Medical Centre, Heerlen, The NetherlandsandMaastricht University Medical Centre +, Maastricht, The Netherlands414
进行中（未招募）
不适用
FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel DiseaseNSTEMI - Non-ST Segment Elevation MIFractional Flow Reserve, MyocardialMyocardial RevascularizationPercutaneous Coronary InterventionCoronary Artery DiseaseNCT03562572Zuyderland Medisch Centrum476
招募中
Unknown
Complete revascularization versus culprit lesion only PCI in NSTEMInon-ST-elevation myocardial infarction (NSTEMI)Multivessel coronary artery diseaseI21.4I25.12I25.13Acute subendocardial myocardial infarctionDRKS00031653eipzig Heart Science gGmbH3,390
已完成
不适用
Clinical Outcomes Utilising Revascularisation and Aggressive Drug EvaluatioISRCTN18172323Department of Veteran Affairs, U.S. Federal Government and McMaster University Faculty of Health Sciences (Canada)2,546
招募中
不适用
REvascularization versus optimal medical therapy on left Ventricular ISchemia reduction: Exploring the associations between ischemia, functional outcome and collaterals in the treatment of Chronic Total Occlusion patientsNL-OMON49007Academisch Medisch Centrum82